Mechanisms of tumor metastasis: Cell biological aspects and clinical implications

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 12, 2000, Pages 682-692

  Engers, Rainer ^a   Gabbert, Helmut Erich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Differentiation; Invasion; Metastasis; Tumor cell dissociation; Tumor dormancy

Indexed keywords

ARTICLE; CANCER INVASION; CANCER THERAPY; CELL DIFFERENTIATION; CELL MIGRATION; CHROMOSOME ABERRATION; CYTOLOGY; DISEASE COURSE; METASTASIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM;

EID: 0033695410     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000148     Document Type: Article

References (125)

1. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression
2. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats
3. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
4. Designing therapies that target tumor blood vessels [news; comment]
5. A pharmacokinetically guided phase II study of carboxyamidotriazole in androgen-independent prostate cancer
6. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
7. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers
8. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
9. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain ina similar manner to TIMP-2
10. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness
11. Adherens junction proteins in tumour progression
12. The E-cadherin/catenin complex in invasion and metastasis
13. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood Vessels
14. Wnt signaling: Why is everything so negative?
15. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions
16. The incidence of late recurrence (greater than 10 years); an analysis of 536 consecutive cases of cutaneous melanoma
17. Steps in tumor metastasis: New concepts from intravital videomicroscopy
18. Changing views of the role of matrix metalloproteinases in metastasis
19. A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells
20. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms
21. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression
22. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts [published erratum appears in Cancer Res 1993 Aug 1; 53(15): 3652]
23. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
24. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia
25. Fumagillin analog in the treatment of Kaposi's sarcoma: A phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team
26. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
27. Development of angiogenesis inhibitors for cancer therapy
28. Current and future strategies to block tumor angiogenesis, invasion, and metastasis
29. In vitro invasiveness of human epithelioid-sarcoma cell lines: Association with cell motility and inverse correlation with the expression of tissue inhibitor of metalloproteinases
30. Retinoids: Present role and future potential
31. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: Multivariate analysis
32. The role of angiogenesis in tumor growth
33. Angiogenesis in cancer, vascular, rheumatoid, and other disease
34. Angiogenesis and angiogenesis inhibition: An overview
35. The role of apoptosis in the inhibition of a secondary tumor by concomitant resistance in a mouse model of metastases
36. Mechanisms of tumor invasion: Evidence from in vivo observations
37. Tumor dedifferentiation: An important step in tumor invasion
38. Terminal differentiation and growth inhibition of a rat rhabdomyosarcoma cell line (BA-HAN-1 C) in vitro after exposure to retinoic acid
39. Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients
40. Tumor-cell dissociation at the invasion front: A new prognostic parameter in gastric cancer patients
41. Prognostic value of E-cadherin expression in 413 gastric carcinomas
42. Modulation of invasive potential in different clonal subpopulations of a rat rhabdomyosarcoma cell line (BA-HAN-1) by differentiation induction
43. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells
44. Integrin signaling
45. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
46. Integrin expression in breast cancer cytology: A novel predictor of axillary metastasis
47. Signal transduction of beta-catenin
48. Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy
49. Perspective: Tumour spread - The problems of latency
50. Coagulation and fibrinolysis in cancer
51. Inhibition of metastases by anticoagulants
52. IL-4 and TNF-alpha induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cells
53. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression [see comments]
54. Diffuse-type gastric cancer: From HandE-diagnosis and molecular pathology to specific therapy
55. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling
56. Cell adhesion molecules in the formation of liver metastasis
57. Regulation of cell adhesion: A central mechanism in the anticancer action of essential fatty acids (review)
58. Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids
59. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease
60. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K
61. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion
62. Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic
63. The regulation of expression of integrin receptors
64. L651582: A novel antiproliferative and antimetastasis agent
65. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers
66. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates
67. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion
68. Cdc42, Rac1, and their effector IQGAP1 as molecular switches for cadherin-mediated cell-cell adhesion
69. Humanization of a mouse antibody against human alpha-4 integrin: A potential therapeutic for the treatment of multiple sclerosis
70. Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents
71. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation
72. Cancer chemoprevention
73. Retinoids and chemoprevention: Clinical and basic studies
74. Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases
75. Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions
76. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation
77. Cancer dormancy: Role of cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgM
78. How and when do tumor cells metastasize?
79. E-cadherin/catenin/cytoskeleton complex: A regulator of cancer invasion
80. Role of morphogenetic factors in metastasis of mammary carcinoma cells
81. Mechanisms of tumour metastasis
82. A role for Rac in Tiam1-induced membrane ruffling and invasion
83. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor
84. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth
85. Autocrine motility factor and its receptor: Role in cell locomotion and metastasis
86. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: Immunohistochemical analysis of 96 lesions
87. Gene expression, cellular diversification and tumor progression to the metastatic phenotype
88. Rho GTPases control polarity, protrusion, and adhesion during cell movement
89. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
90. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness [published erratum appears in Nature 1997 Jul 10;388(6638): 210]
91. A causal role for E-cadherin in the transition from adenoma to carcinoma
92. Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation
93. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies
94. Tumor dormancy and cell signaling: Anti-mu-induced apoptosis in human B-lymphoma cells is not Cafised by an APO-1-APO-1 ligand interaction
95. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis, and angiogenesis
96. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)
97. Membrane ruffling and signal transduction
98. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
99. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells
100. Signal transduction by cell adhesion receptors
101. Loss of alpha 1 beta 1 and reduced expression of other beta 1 integrins and CAM in lung adenocarcinoma compared with pneumocytes
102. Integrins as signaling molecules and targets for tumor therapy
103. Retinoids in the chemoprevention of bladder cancer
104. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase
105. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue
106. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion
107. Cell migration as a five-step cycle
108. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation
109. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
110. Alpha 6 beta 4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Continuous expression of laminins but not that of collagen VII is preserved in invasive parts of the carcinomas: Implications for acquisition of the invading phenotype
111. CAI: Effects on cytotoxic therapies in vitro and in vivo
112. Prognostic significance of urokinasetype plasminogen activator expression in squamous cell carcinomas of the esophagus
113. Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)
114. Motility and invasive potency of murine T-lymphoma cells: Effect of microtubule inhibitors
115. Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established
116. Inhibitors of angiogenesis in a Clinical perspective
117. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4
118. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice
119. The alpha 6-integrin receptor in pancreatic carcinoma
120. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells
121. Molecular and functional analysis of cadherin-based adherens junctions
122. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development
123. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells